Investor Presentation
Melbourne, April 27, 2017 AEST (ABN Newswire) - Bluechiip Ltd (
ASX:BCT) is pleased to provide the Company's latest Investor Presentation.
Bluechiip Highlights
- Highly differentiated, expanding, protected core technology
- Chasing immediate, addressable market of US$250 million + from 3 recently executed licence and supply agreements
o Genea Biomedx - IVF Market (US$20M) with upcoming product launch through Merck
o Planet Innovation - Cryopreservation, transport and life sciences (US$30M) market opportunities
o Labcon North America - Biopreservation market (US$200M) with initial 2ml vial market ($40M)
- Growing target bio-preservation market (>US$2B) & very large adjacent markets
- Dramatically increasing partner pipeline with well advanced product development
- Growing initial repeat licence, service and product revenues
- Expected significant revenue growth in FY'18 on partner's product launch
To view the full presentation, please visit:
http://abnnewswire.net/lnk/2Y01PE9J
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
